For laboratory research use only - not for human consumption

Hub · Are peptides legal in Australia? Research peptide schedule status

What Schedule 4 and Appendix D mean for research peptides

Schedule 4 of the Poisons Standard is headed 'Prescription only medicines and prescription animal remedies'. The Poisons Standard is Australia's national list that sorts medicines and poisons. Appendix D, clause 5 is a numbered table placed after the lists. It names poisons that 'must not be possessed by a person without authority'. In F2026L01327, the October 2026 edition, the two lists are separate. Some research peptides sit on both. Peptides are short chains of amino acids, the building blocks of proteins (checked 1 October 2026).

Published 2026-10-04Updated 2026-10-04Written by Form Laboratories research team7 min read

Think about the last time a cold blocked your nose. Some remedies sat on a shelf within reach. Others came across the counter only after the pharmacist saw a prescription, which is a doctor's written order. Australia sorts substances in a similar way, on a national list. The Peptides and Australian Law page reads that list peptide by peptide.

This page looks at two labels from the list. It says what Schedule 4 and Appendix D each mean. It quotes the clause each time. It also puts the two side by side in a table. Nothing here is legal advice. Nothing here says what a person may lawfully do. The Western Australian law page adds the state rules.

  • GuideThe Peptides and Australian Law pageSchedule 4 and Appendix D status of the catalogue research peptides read in the October 2026 Poisons Standard, read 14 October 2026, with the TGA import rules and sport rules.
  • GuideThe Western Australian law pageHow the Poisons Standard reaches Western Australia through the Medicines and Poisons Act 2014, and what the TGA says a research-use label does not do.

Key facts

Key facts for What Schedule 4 and Appendix D mean for research peptides
Document readTherapeutic Goods (Poisons Standard, October 2026) Instrument 2026
Register IDF2026L01327
Made28 September 2026
In force from1 October 2026
Date read1 October 2026, legislation.gov.au
Schedule 4 headingPrescription only medicines and prescription animal remedies
Appendix D clause readClause 5, a table of 41 numbered rows
Catalogue peptides in both lists4
Held, no status stated2 catalogue compounds
Not coveredLater editions and blended products
Federal Register of Legislation, F2026L01327, Schedule 4 and sections 11 and 12

What does Schedule 4 mean?

Schedule 4 is one of the numbered lists in the Poisons Standard. Its heading in the October 2026 edition reads 'Prescription only medicines and prescription animal remedies'. A schedule is a list that sorts named substances by how tightly the law controls them. The instrument is the legal document that holds the lists. Section 12(3) is a numbered rule in its main text. It ranks the schedules from most to least strict: 9, 10, 8, 4, 7, 3, 2, 6 and 5. That puts Schedule 4 fourth from the top. A Schedule 4 entry is a sorting label. It says nothing about any person's own situation (Federal Register of Legislation, F2026L01327, checked on 1 October 2026).

Read the heading plainly. 'Prescription only' says the list is about medicines that need a prescription. The schedule is a set of named entries. One entry can name a single substance or a named group of related substances.

Section 11 lists exceptions to Part 2, the instrument's 'controls on substances'. This page does not go through them. Always read a scheduled name together with them (F2026L01327, section 11).

Federal Register of Legislation, F2026L01327, Appendix D, clause 5

What is Appendix D in the Poisons Standard?

Appendix D is a set of tables placed after the schedules in the Poisons Standard. This page reads clause 5 of it, because its heading says possession without authority is illegal. The clause's introduction says the table 'specifies poisons' that a person may not hold 'without authority'. It gives 'possession other than in accordance with a legal prescription' as an example. A clause is a numbered part of an appendix. An item is a numbered row in its table. In F2026L01327, clause 5 has 41 items (read on 1 October 2026).

The clause 5 table has two columns, Item and Poison. Each row is a number and a poison's name. No row describes a product, a use or a person.

'Without authority' is the instrument's own wording. Its example, a legal prescription, shows that authority can exist. This page does not say who has authority in any case.

Federal Register of Legislation, F2026L01327, Schedule 4 and Appendix D, clause 5Molecular Metabolism 2018

Which research peptides appear in both lists?

Four research peptides in the Form Laboratories catalogue appear in both Schedule 4 and Appendix D, clause 5 of F2026L01327, the October 2026 edition (checked 1 October 2026, world time, UTC). BPC-157 is at item 5. It is a piece of a protein found in stomach juice (Sikirić et al., 1993). CJC-1295 is at item 7. It is a lab-made copy of growth-hormone-releasing hormone, a body signal (Teichman et al., 2006). Ipamorelin is at item 25. It is a small peptide that prompted growth hormone release in cell and animal studies (Raun et al., 1998). TB-500 is at item 38. Each of the four Schedule 4 entries starts with a # marker, such as '# BPC-157.'.

TB-500 is a research-peptide name. The list shows it apart from thymosin beta 4, which has entries of its own. The CJC-1295 entry carries a CAS number, a registry number that names one chemical: '# CJC-1295 (CAS No. 863288-34-0).'. The instrument never uses the catalogue label 'No DAC'. So it is left open whether that form falls under the entry. Guides: BPC-157, CJC-1295 with ipamorelin and TB-500.

Tirzepatide is the contrast. It is a peptide with a fatty acid attached. It switches on two gut-hormone receptors, which are docking sites on cells for body signals (Coskun et al., 2018). Its Schedule 4 entry reads 'TIRZEPATIDE.' with no # marker. Clause 5 has no tirzepatide item.

  • GuideBPC-157A plain-English guide to BPC-157: what it is, the tissue-repair research (in cells and animals), and where the human evidence stands.
  • GuideCJC-1295 with ipamorelinA plain-English guide to CJC-1295 (No DAC), Ipamorelin, the with DAC caveat, and the compliance limits around this research set.
  • GuideTB-500A plain-English guide to TB-500: the actin-binding fragment of thymosin beta-4, what's been studied, and why it isn't the same as the full protein.
Federal Register of Legislation, F2026L01327, Schedule 4 and Appendix D, clause 5

How do Schedule 4 and Appendix D differ?

Schedule 4 and Appendix D, clause 5 answer different questions about a named substance. Schedule 4 puts the substance in a list headed for prescription only medicines. Appendix D, clause 5 puts a poison's name in a numbered table headed for possession without authority. A name can sit in one list and not the other. In the October 2026 edition, tirzepatide has a Schedule 4 entry and no clause 5 item. Each list has its own wording and its own place in the instrument (F2026L01327, read on 1 October 2026).

The table after these sections puts the two side by side. Each row asks one question. The last column names the part of the instrument that gives the answer.

Federal Register of Legislation, F2026L01327, sections 7 and 12

Does a missing entry mean a substance is allowed?

No. A missing entry in Schedule 4 or Appendix D, clause 5 tells you nothing about permission, because section 7 widens what a name can reach. Section 7 of F2026L01327 says that, unless the contrary intention appears, a reference to a substance includes 'every … derivative of the substance' and 'a preparation or admixture containing any proportion of the substance'. A derivative is a substance made by changing the original. An admixture is a mixture. Section 12(1) adds that a preparation holding two or more poisons follows each schedule that applies to them (Federal Register of Legislation, checked on 1 October 2026).

The 1 October 2026 search found no individual entry for five other compounds in the Form Laboratories catalogue. The hub page names them. This does not mean any of them is lawful, approved or free to possess. This page draws no group-heading conclusion for any compound.

  • GuideThe hub pageSchedule 4 and Appendix D status of the catalogue research peptides read in the October 2026 Poisons Standard, read 14 October 2026, with the TGA import rules and sport rules.
Federal Register of Legislation, F2026L01327, sections 2 and 4 and Appendix L

What changes between editions of the Poisons Standard?

Item numbers can change between editions of the Poisons Standard while an entry stays the same. TB-500 sat at item 35 of Appendix D, clause 5 in the June 2026 edition, F2026L00633. It sits at item 38 in the October 2026 edition, with its entry text unchanged (read on 1 October 2026). Section 4(1) of the October instrument repeals (cancels) the June instrument. Section 2 starts the October instrument on 1 October 2026. BPC-157, CJC-1295 and ipamorelin kept items 5, 7 and 25 across the two editions.

Tirzepatide's Appendix L entry moved from item 40 to item 41 in the same way. Appendix L is a table of extra warning statements for some human medicines (F2026L01327).

Federal Register of Legislation, F2026L01327, sections 4 and 5

Evidence limits

What can this page not tell you?

This page reads Schedule 4 and Appendix D from one document on one date. The reading shows what the lists contain. It does not show what any person may do. The text comes from the Federal Register of Legislation, F2026L01327 (the October 2026 edition), checked on 1 October 2026. Later editions may differ, and this page does not cover them. Import rules, sport rules and state and territory laws are also outside it. GHK-Cu (the copper form of a peptide called GHK) and tesamorelin (a peptide) come from the Form Laboratories catalogue record. They are held, so the page states no status for either. Blended products are not covered.

The Reader's guide and the Index that come with the Poisons Standard are not part of the instrument (section 5). So this page reads the entries themselves, not the Index.

Comparison

Schedule 4 and Appendix D, clause 5 compared clause by clause in F2026L01327, read 1 October 2026.

Comparison: What Schedule 4 and Appendix D mean for research peptides
Point of comparisonSchedule 4Appendix D, clause 5Where the instrument says so
Heading'Prescription only medicines and prescription animal remedies''Poisons for which possession without authority is illegal'The heading of each part
Form of the listNamed entries, each its own lineA table of numbered items with two columns, Item and PoisonSchedule 4; Appendix D, clause 5
Plain readingA classification: the name belongs to the prescription only listPoisons a person may not hold without authority; a legal prescription is the instrument's exampleSchedule 4 heading; Appendix D, clause 5 introduction
Place in the rankingFourth, from most to least restrictiveNot ranked, because section 12(3) lists schedules onlySection 12(3)
BPC-157'# BPC-157.'Item 5Schedule 4; clause 5 table
CJC-1295'# CJC-1295 (CAS No. 863288-34-0).'Item 7Schedule 4; clause 5 table
Ipamorelin'# IPAMORELIN.'Item 25Schedule 4; clause 5 table
TB-500'# TB-500.'Item 38Schedule 4; clause 5 table
Tirzepatide'TIRZEPATIDE.', no # markerNo itemSchedule 4; clause 5 table
What a missing name showsNothing about permissionNothing about permissionSection 7
Change from June 2026Entry text for the four peptides unchangedItem numbers can move: TB-500 went from item 35 to item 38Sections 2 and 4

FAQ

What does Schedule 4 mean in Australia?

Schedule 4 is the Poisons Standard list under the heading 'Prescription only medicines and prescription animal remedies'. The October 2026 edition, F2026L01327, names BPC-157, CJC-1295, ipamorelin, TB-500 and tirzepatide in it. A Schedule 4 entry sorts a substance. It decides nothing about any person's situation.

What does Appendix D, clause 5 list?

Appendix D, clause 5 is a numbered table of 41 poisons. The instrument's heading calls possession of them without authority illegal. In F2026L01327, BPC-157 is at item 5 and TB-500 is at item 38.

Is every Schedule 4 peptide also in Appendix D?

No. Tirzepatide has a Schedule 4 entry written without a # marker. It has no Appendix D, clause 5 item. BPC-157, CJC-1295, ipamorelin and TB-500 have both.

Why do Appendix D item numbers change?

Each edition of the Poisons Standard is a new instrument. Its tables are renumbered when entries move. TB-500 moved from item 35 to item 38 between the June 2026 and October 2026 editions. Its entry text stayed the same. So always give the edition with a number.

Citations

4 sources
  1. Sikirić P et al. Journal of Physiology-Paris. 1993;87(5):313-327.
    doi:10.1016/0928-4257(93)90038-U

  2. Teichman SL et al. Journal of Clinical Endocrinology & Metabolism. 2006;91(3):799-805.
    doi:10.1210/jc.2005-1536

  3. Raun K et al. European Journal of Endocrinology. 1998;139(5):552-561.
    doi:10.1530/eje.0.1390552

  4. Coskun T et al. Molecular Metabolism. 2018;18:3-14.
    doi:10.1016/j.molmet.2018.09.009

Written by

Form Laboratories research team

Perth, Western Australia. We supply research-use-only reference material.

Written in-house
These articles are written and maintained by our own research team, not by a named clinician.
Built from the record
Every figure comes from published literature, listed in full above with a link to the original paper.
No use directions
We describe what the research measured. We give no use directions, preparation steps or advice.

Form Laboratories supplies research-use-only reference material. This article is an educational summary of published third-party literature. It is not medical advice, not a use instruction, and research material is not for human or animal use.

2026 Form Laboratories - Research use only - Perth WAPerth WA 6000 - dispatched Australia-wide via Australia Post or CouriersPlease